![Pascal Touchon](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 788 528 $ al 31/08/2026
Dr. Pascal Touchon is a Partner at Jeito Capital SASU and an Independent Director at MedinCell SA. He is on the Board of Directors at MedinCell SA and Ipsen SA. Dr. Touchon was previously employed as a Chairman by Atara Biotherapeutics, Inc. and a SVP-Global Head Cell & Gene by Novartis Oncology, Inc. He also served on the board at Dantari, Inc., Genoptix, Inc., Cogen Immune Medicine, Inc. and Navigate BioPharma Services, Inc. He received his MBA from INSEAD and a doctorate degree from Université Toulouse III - Paul Sabatier.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 10/06/2025 | 77.955 ( 0,78 % ) | 693 800 $ | 31/08/2026 | |
IPSEN SA 0 % | 31/12/2025 | 500 ( 0 % ) | 94 728 $ | 31/08/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| IPSEN | Director/Miembro de la Junta | 01/10/2023 |
| MEDINCELL S.A. | Director/Miembro de la Junta | 01/03/2025 |
Jeito Capital SASU
 Jeito Capital SASU Investment ManagersFinance Jeito Capital is an active manager which seeks investment opportunities in companies located in Europe. The firm targets companies operating in the fields of biotech and biopharma. It provides financing for early stage capital requirements. | Inversor de Capital Privado | 01/06/2025 |
| Empresas | Cargo | Fin |
|---|---|---|
| ATARA BIOTHERAPEUTICS, INC. | Director Ejecutivo | 09/09/2024 |
Cogen Immune Medicine, Inc.
 Cogen Immune Medicine, Inc. Pharmaceuticals: MajorHealth Technology Develops immune medicines | Director/Miembro de la Junta | 01/02/2020 |
Navigate Biopharma Services, Inc.
 Navigate Biopharma Services, Inc. BiotechnologyHealth Technology Operates as a testing laboratory that designs biomarker solutions | Director/Miembro de la Junta | - |
Dantari, Inc.
 Dantari, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that engages in creating breakthrough medicines for the treatment of cancer and serious diseases | Director/Miembro de la Junta | - |
Genoptix, Inc.
 Genoptix, Inc. Medical/Nursing ServicesHealth Services Provides cancer laboratory testing services | Director/Miembro de la Junta | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 11 |
|---|---|
Novartis Oncology, Inc.
 Novartis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
Genoptix, Inc.
Genoptix, Inc. Medical/Nursing ServicesHealth Services Provides cancer laboratory testing services | Health Services |
Ipsen SA
 Ipsen SA Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
INSEAD
 INSEAD Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Université Toulouse III - Paul Sabatier
 Université Toulouse III - Paul Sabatier Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
MedinCell SA
 MedinCell SA Pharmaceuticals: MajorHealth Technology Provides therapeutic solutions | Health Technology |
Atara Biotherapeutics, Inc.
 Atara Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Pioneers the development of transformative therapies for patients with serious diseases including solid tumors, hematologic cancers, and autoimmune diseases | Health Technology |
Cogen Immune Medicine, Inc.
Cogen Immune Medicine, Inc. Pharmaceuticals: MajorHealth Technology Develops immune medicines | Health Technology |
Jeito Capital SASU
Jeito Capital SASU Investment ManagersFinance Jeito Capital is an active manager which seeks investment opportunities in companies located in Europe. The firm targets companies operating in the fields of biotech and biopharma. It provides financing for early stage capital requirements. | Finance |
Navigate Biopharma Services, Inc.
Navigate Biopharma Services, Inc. BiotechnologyHealth Technology Operates as a testing laboratory that designs biomarker solutions | Health Technology |
Dantari, Inc.
Dantari, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that engages in creating breakthrough medicines for the treatment of cancer and serious diseases | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
